Agents of Last Resort
Authors:
- 1 December 2020
- journal article
- review article
- Published by Elsevier in Infectious Disease Clinics of North America
- Vol. 34 (4) , 723-750
Abstract
No abstract availableKeywords
Funding Information
- National Key Research and Development Program of China (2018YFC1200100, 2018YFC1200105)
This publication has 170 references indexed in Scilit:
- Hetero- and adaptive resistance to polymyxin B in OXA-23-producing carbapenem-resistant Acinetobacter baumannii isolatesAnnals of Clinical Microbiology and Antimicrobials, 2013
- Pharmacokinetics of Polymyxin B in a Patient With Renal Insufficiency: A Case ReportClinical Infectious Diseases, 2011
- Impaired Virulence and In Vivo Fitness of Colistin-Resistant Acinetobacter baumanniiThe Journal of Infectious Diseases, 2011
- An Outbreak of Infection due to β‐LactamaseKlebsiella pneumoniaeCarbapenemase 2–ProducingK. pneumoniaein a Greek University Hospital: Molecular Characterization, Epidemiology, and OutcomesClinical Infectious Diseases, 2010
- Structure−Activity Relationships of Polymyxin AntibioticsJournal of Medicinal Chemistry, 2009
- Resistance to Colistin in Acinetobacter baumannii Associated with Mutations in the PmrAB Two-Component SystemAntimicrobial Agents and Chemotherapy, 2009
- Synthesis of and evaluation of lipid A modification by 4-substituted 4-deoxy arabinose analogs as potential inhibitors of bacterial polymyxin resistanceBioorganic & Medicinal Chemistry Letters, 2007
- Heteroresistance to Colistin in Multidrug-Resistant Acinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 2006
- Colistin Methanesulfonate Is an Inactive Prodrug of Colistin against Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 2006
- Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*Critical Care Medicine, 2006